Change in TB diagnostic profile after introduction of GeneXpert MTB/RIF assay in National TB Program of Armenia, 2013-2017

Introduction: In 2013, the National Tuberculosis (TB) Program of Armenia introduced GeneXpert MTB/RIF (Xpert) assay to address World Health Organization (WHO) target of 80% (2020) of notified new and relapse TB cases to be tested with WHO recommended rapid diagnostic methods. This study aimed to as...

Descrición completa

Detalles Bibliográficos

Principais autores:	Eduard Kabasakalyan, Karapet Davtyan, Viktorya Cholakyans, Alvard Mirzoyan, Karine Kentenyants, Diana Petrosyan, Armen Hayrapetyan, Himanshu A Gupte
Formato:	Artigo
Idioma:	Inglês
Publicado:	The Journal of Infection in Developing Countries 2019-05-01
Series:	Journal of Infection in Developing Countries
Assuntos:	Tuberculosis GeneXpert MTB/RIF Diagnosis NRL Laboratory
Acceso en liña:	https://jidc.org/index.php/journal/article/view/10920
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!